In the specialized world of biochemical resear Elamipretide is an investigational drug being developed to treat mitochondrial diseases, yet to be approved by the FDA, but has received orphan drug status. ch and cellular study, few compounds have garnered as much fascination as the sa31 peptide, widely known in scientific literature as SS-31 or Elamipretide. As someone who follows advancements in mitochondrial research closely, I h SS-31 as a Mitochondrial Protectant in the Treatment of ave spent a significant amount of time reviewing the data surrounding this unique molecule. It is important to note that my interest is May 22, 2024 — Elamipretide (MTP-131, SS-31) is a cardiolipin peroxidase inhibitor and mitochondria-targeted peptide. Elamipretide alleviates mitocho. stri by X Du · 2024 · Cited by 56 — Elamipretide (SS-31), a novel synthetic mitochondrial-targeted antioxidant, has emerged as a promising candidate with extensive therapeutic potential. ctly limited to laboratory-based inquiry and personal observation; this content is for informational purposes only and does not constitute medical advice.
Understanding the Chemistry of the SS-31 Peptide
At its core, the SS SS-31 Peptide: Research in Mitochondrial Functionality -31 peptide is a synthetic mitochondria-targeting tetrapeptide. Its st SS-31 (Elamipretide) is a water-soluble, cell-permeable mitochondria-targeting tetrapeptide. It selectively concentrates >1,000-fold in the inner mitochondrial ructural design is what sets it apart from other compounds in the field. It is a small peptide, specifically engineered for rigorous scientific inquiry, which allows it to penetrate cellular barriers with precision.
The primary mechanism that makes this molecule so compelling to researchers is its apparent capacity to accumulate within the inner mitochondrial membrane. Once it reaches this site, it binds with high affinity to cardiolipin. Because cardiolipin is a phospholipid uniquely positioned within the mitochondrial matrix, this binding action essentially serves as a cardiolipin peroxidase inhibitor and mitochondria-targeted peptide. By stabilizing this interaction, the molecule helps maintain the physical integrity of the mitochondrial l by X Du · 2024 · Cited by 56 — Elamipretide (SS-31), a novel synthetic mitochondrial-targeted antioxidant, has emerged as a promising candidate with extensive therapeutic potential. andscape.
Why Researchers Focus on Mitochondrial Function
The interest in this compound stems from the fact that SS31 is helping to put a stop to that vicious cycle of mitochondrial dysfunction that often occurs during cellular stress. When I first began reading about this, it became clear that the goal is not just energy production, but the preservation of cellular resilience.
Many studies suggest that SS-31 is a mitochondria-targeting antioxidant that works by scavenging reactive oxygen species (ROS). By mitigating oxidative stress, the compound supports the efficiency of the electron transp Because mitochondrial dysfunction is linked to aging, SS-31 may: - Improve cellular resilience - Reduce oxidative stress - Support healthier ort chain. Whether it is in the context of cognitive performance in aged animal models or structural health, the data often highlights how the molecule repairs the mitochondria when they are under strain or in a state of overload.
Key Facts About Elamipretide (SS-31)
For those looking into the technical specifications, here is a summary of what makes this compound a subject of such intense study:
* Chemical Identity: It is a tetrapeptide compound with the sequence D-Arg-dimethyl-Tyr-Lys-Phe-NH2.
* Targeting Mechanism: I SS-31 (Elamipretide) 50mg 3ML | Mitochondrial Research t is specifically designed to target mitochondria, where it concentrates over 1,000-fold.
* Research Applications: It is frequently used in studies regarding cellular energy, the inflammatory response, and the maintenance of mitochondrial number and function.
* Terminology: You will often see it referred to as MTP-131, Bendavia, or Elamipretide. While it is an investigational drug being developed to treat mitochondrial diseases—and is a medication used for the treatment of Barth syndrome in specific clinical contexts—my focus remains purely on its role as a research-grade tool.
Observations on Research Trends
When researching the sa31 peptide, it is common to encounter discussions regarding its potential to improve cellular resilience. In my own review of the available literature, I have noticed that the focus is consistently on its ability to protect against mitochondrial dysfunction.
While the scientific community continues to explore the boundaries of this research, it is vital to remember that all materials labeled as "research peptides" are intended for laboratory use only. The sophisticated nature of this molecule—acting as a modulator of the inner mitochondrial membrane—requires a deep understanding of biochemistry.
Final Thoughts
The study of the SS-31 peptide represents a fascinating intersection of chemistry and cellular biology. Whether it is being analyzed for its antioxidant properties or its role as a mitochondrial protectant, the data continues to paint a picture of a compound that plays a critical role in how we understand cellular health. For those of us observing these developments, the progress in understanding how to better support our cellular machinery remains one of the most exciting aspects of modern biochemical inquiry.
Always ensure that any information you gather is from verified, peer-reviewed sources, and keep in mind that the landscape of peptide science is constantly evolving as new data emerges from the lab.